Rain Oncology Inc (NAS:RAIN)
$ 1.21 0 (0%) Market Cap: 44.02 Mil Enterprise Value: -32.85 Mil PE Ratio: 0 PB Ratio: 0.65 GF Score: 22/100

Rain Oncology Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 05:00PM GMT
Release Date Price: $11.27 (-9.62%)
Unidentified Analyst

Good morning, everyone. Thank you for joining us for the 41st JPMorgan Healthcare Conference. We're thrilled to have you here, and we're thrilled to have Rain Oncology. We've got Avanish Vellanki here, who's going to -- President and CEO of Rain, who's going to kick us off.

Avanish Vellanki
Rain Oncology Inc. - Co-Founder, CEO & Chairman

Thanks, James. Thanks, everyone. It's a pleasure to be here. We want to thank the conference organizers and our friends at JPMorgan for allowing us to share our story today. My name is Avanish Vellanki, Co-Founder and CEO of Rain Oncology. Before we get started on a more lighthearted note, and given the weather that we're having in San Francisco, I think it's forced upon us to explain the name, Rain. And so let me tell you the story. In 2017, when I incorporated the company, California was in the midst of a drought. And as far as the eye could see, it was just different shades of brown, everything was dying and patches of dirt where the grass used to be, and so it's really dawned on me how much of a need

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot